Copyright © 1993 Published by Elsevier Inc.
Lead article
Received 14 October 1992;
Abstract
Chromosome analysis was performed on 304 samples of 249 consecutive patients examined for a possible bone tumor. The series consisted of 86 nonneoplastic disorders, 108 benign and 78 malignant primary bone tumors, and 32 other bone malignancies. In the group of nonneoplastic disorders, one sample from an infectious lesion demonstrated a clonal chromosome aberration, i.e., additional material in the short arm of chromosome 1. Simple clonal aberrations were noted in six of 75 successfully cultured benign tumors, e.g., a chondromyxoid fibroma with an insertion type translocation from 2p21p25 to 5q13 and 2p deletion and a nonossifying fibroma with del(4)(p14). Complex clonal aberrations were evident in 21 of 54 successfully cultured malignant primary bone tumors and eight of 21 secondary bone malignancies. The complexity of clonal aberrations correlated with the grade of malignancy as the osteosarcomas and chondrosarcomas of high-grade demonstrated chaotic abnormalities. Six Ewing's sarcomas demonstrated the t(11;22)(q24;q12); in one this was the sole abnormality, and in five additional changes were evident: der(1;16)(q10;p10) in one. Homogeneously staining elongated areas interpreted as HSR were observed in three patients, all of whom had a highly malignant tumor. The most frequent nonclonal abnormality was telomeric association, which was observed mainly in giant cell tumors.
This study was supported by the Emil Aaltonen Foundation (M.T.), the Finnish Academy of Sciences (I.E.), by a grant donated by Zeneca Pharma to the Foundation for the Finnish Cancer Institute (M.T.), the Finnish Cancer Society (S.K.), the Sigfrid Jusélius Foundation (S.K.) and the Vuorisalo Foundation (M.T.).
Address reprint requests to: Maija Tarkkanen, M.D., Department of Medical Genetics, P.O. Box 21 (Haartmaninkatu 3) SF-00014 University of Helsinki, Finland. 





E-mail Article
Add to my Quick Links

Cited By in Scopus (56)





